key: cord-0953108-15ex09is
authors: Bao, Cuiping; Liu, Jun; Li, Yiming
title: Response to “Tomographic Findings and Thrombogenic Effects of COVID-19”
date: 2020-10-31
journal: J Am Coll Radiol
DOI: 10.1016/j.jacr.2020.08.023
sha: a65fb7634a786dae55edce8492b2622c2a610757
doc_id: 953108
cord_uid: 15ex09is

nan

Response to "Tomographic Findings and Thrombogenic Effects of COVID-19"

We thank the authors of "Tomographic Findings and Thrombogenic Effects of COVID-19" for their comments on our work [1] . Patients infected by coronavirus disease 2019 (COVID-19) have typical CT features, and chest CT plays a key role in assisting diagnosis of COVID-19. This is especially true for patients with a history suggestive of COVID-19 and negative reverse transcription polymerase chain reaction test at initial presentation. In these cases, abnormal chest CT could be used to aid early detection [2] . In the early stages of the outbreak, we retrieved the articles that only analyzed typical CT features, such as ground glass opacities and consolidation. During that time, the infection of COVID-19 was poorly understood. The retrieved articles in our study did not consider pulmonary embolism.

As we learn more about COVID-19, a growing number of studies have reported that patients with COVID-19 infection are prone to thromboembolic disease, especially those hospitalized in intensive care units who are at higher risk of pulmonary embolism [3] . Both viral pneumonias and embolic events could lead to diffuse alveolar edema and interstitial inflammation, and their typical imaging findings are similar.

For the diagnosis of pulmonary embolism, the following aspects are needed in our opinion. First, CT pulmonary angiography is considered as the standard for diagnosis of pulmonary embolism [4] . Second, there are differences in appearance on chest CT images between COVID-19 and pulmonary embolism, such as peripheral wedgeshaped density and area of pulmonary oligemia distal to the occluded pulmonary artery in patients with pulmonary embolism. Finally, the diagnosis of embolism needs a prospective evaluation, according to systematic assessment of clinical symptoms, CT features, and D-dimers. Thus, we believe that patients with highly elevated D-dimer levels should be assessed by CT pulmonary angiography [5] . Nevertheless, we agree that more attention should be paid to higher risks of thrombogenic effects among patients with COVID-19. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51 

Coronavirus disease 2019 (COVID-19) CT findings: a systematic review and meta-analysis

Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2

Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis

Pulmonary infarction secondary to pulmonary thromboembolism in COVID-19 diagnosed with dual-energy CT pulmonary angiography

Chest CT in COVID-19 pneumonia: a review of current knowledge